Patent · US Active

Vaccine comprising drug and parasite administration

US11406694B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

GRIFFITH UNIVERSITY · AU

Inventors

Michael Good · Forsayth, AU
Danielle STANISIC · Boomley, AU
Leanne Low · Boomley, AU

Key dates

Filing date	Oct 24, 2016
Grant date	Aug 9, 2022
Priority date	—
Expiry date	Oct 24, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Apicomplexan parasites or red blood cells infected with apicomplexan parasites are administered to an animal in combination with a delayed death agent that initially allows parasite replication but subsequently kills the apicomplexan parasites. This allows the elicitation of an immune response by the animal while preventing the parasites producing a serious infection of the animal. The apicomplexan parasites may be malaria or babesia parasites. The delayed death agent may be a tetracycline class antibiotic, a macrolide antibiotic or a lincosamide antibiotic.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.